Anti-HER2 CAR T cells could produce remarkable levels of IFN-γ and IL-2 upon detecting HER2-expressing autologous GBM cells, ultimately leading to the persistent regression of autologous GBM xenografts. Here, ERBB2 is linked to glioblastoma.